Insider Trading April 24, 2026 03:10 PM

NB Bancorp Director Hope Pascucci Executes $389,000 Stock Purchase

Insider transaction follows recent price volatility as director increases common stock position.

By Marcus Reed NBBK
NB Bancorp Director Hope Pascucci Executes $389,000 Stock Purchase
NBBK

A recent regulatory filing from the SEC reveals that Hope Pascucci, a member of the board of directors at NB Bancorp, Inc. (NASDAQ: NBBK), has significantly increased her stake in the company. The transactions, which occurred on April 24, 2026, involved a total acquisition of $389,281 worth of common stock. This move comes during a period of notable price movement for the company's shares, which saw a decline of nearly 15% over the preceding week, dropping from a level of $21.45 to approximately $19.56.

Key Points

  • Director Hope Pascucci purchased 20,000 shares of NB Bancorp totaling $389,281.
  • The stock purchase follows a nearly 15% decline in share value from $21.45 to $19.56.
  • Quarterly earnings per share of $0.36 were driven by increased net interest income.

Director Increases Stake Amid Share Price Volatility

In a significant move for NB Bancorp, Inc. (NASDAQ: NBBK), director Hope Pascucci has expanded her holdings through a series of recent transactions. According to filings submitted to the SEC, Ms. Pascucci acquired 20,000 shares of common stock on April 24, 2026. These purchases were executed in two separate transactions at price points ranging from $19.4392 to $19.4889 per share.

The timing of this acquisition follows a week of downward pressure on the stock, which fell nearly 15% from $21.45 to around $19.56. Despite this recent volatility, analysis suggests that NBBK may be trading at undervalued levels, supported by the company's "GOOD" rating for financial health.

Detailed Ownership Breakdown

Following these latest transactions, Ms. Pascucci's direct ownership in NB Bancorp common stock stands at 142,402 shares. This total includes specific restricted stock components: one portion is scheduled to vest at an annual rate of 20%, beginning on April 24, 2026, while another portion is set for a full 100% vesting on January 2, 2027. Furthermore, Ms. Pascucci maintains an indirect interest in the company through her spouse, who holds 80,000 shares of common stock.

Financial Performance Context

The insider activity occurs against a backdrop of recent financial reporting from NB Bancorp Inc. The company recently disclosed an increase in quarterly profits, a trend attributed to higher net interest income. For the first quarter, earnings per share were reported at $0.36, which was largely consistent with analyst expectations of $0.38. While these results reflect stable performance and aligned projections, the stock experienced a slight decline during after-market trading following the announcement.


Key Market Observations

  • Insider Confidence: The purchase of nearly $390,000 in shares by a director suggests internal positioning during a period of price decline.
  • Earnings Stability: NB Bancorp's quarterly profit growth was driven by net interest income, meeting closely anticipated analyst targets despite minor fluctuations in after-market trading.

Risks and Uncertainties

  • Market Volatility: The stock recently experienced a sharp 15% decline within a single week, highlighting short-term price sensitivity.
  • Earnings Variance: While results were largely in line with projections, the slight difference between actual EPS ($0.36) and estimated EPS ($0.38) illustrates the narrow margins of financial expectations.

Risks

  • Recent share price volatility, including a 15% drop over one week.
  • The minor discrepancy between reported EPS of $0.36 and analyst estimates of $0.38.

More from Insider Trading

United Rentals Executive Executes Stock Sale Amid Recent Price Surge Apr 24, 2026 Nuveen Credit Strategies Income Fund Portfolio Manager Executes Significant Common Stock Purchase Apr 24, 2026 Nuveen Floating Rate Income Fund Portfolio Manager Executes Significant Stock Purchase Apr 24, 2026 Westwood Holdings Group Director Emerita Executes Scheduled Stock Sales Apr 24, 2026 United Therapeutics CFO Executes $5.7 Million Stock Sale Amidst Recent Valuation Gains Apr 24, 2026